Skip to content

Assessment of tear breakup time when wearing lipid-laden daily disposable contact lenses

Comparing comfort level after wearing lipid-laden contact lenses with control contact lenses (without lipids) and market contact lenses by assessing tear breakup time and tear lipid layer thickness among subjects with dry eyes who are experienced or new contact lens wearers

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12623000337673
Enrollment
16
Registered
2023-03-31
Start date
2023-07-26
Completion date
2023-09-25
Last updated
2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Contact lens discomfort and its associated dryness are the primary reason to discontinue using contact lenses. In addition, users with decreased tear volume are more prone to be intolerant to soft contact lenses. The lipids of the tear film are produced in the meibomian gland in the eyelids and this lipid is delivered from the meibomian gland to the eye to form part of the tear film lipid layer. This layer promotes tear film stability and prevents drying of the ocular surface. Several of these lipids help stabilise and spread tears across the ocular surface and retard tear evaporation. The amount of lipids in tears is reduced in people with dry eye, and dry eye is related to contact lens comfort. Contact lens discomfort is worse when people’s meibomian glands are blocked. Therefore, we hypothesize that adding lipids back to the eye during contact lens wear will help form a stable tear film and reduce dry eye sensations. We and many others have shown that delivering components from contact lenses is preferable to delivering by eye drops as more of the component remains on the eye. We have produced lipids in the form of small particles that are stabilized using a surfactant compound, and shown that these can be imbedded into contact lenses. A small-scale study has shown that these lipid-containing contact lenses do not increase redness or other clinical measures associated with toxic responses. Now, we would like to test these lenses in a larger study and measure whether lens wearers can notice an improvement in symptoms during wear. In this study, participants will randomly wear lipid-imbibed lenses (O-L), control lenses that contain only the small particles of surfactant with no lipid (C-L), and normal commercially available contact lenses (M-L). The same lens will be worn in both eyes, all participants will wear all 3 lens types (in total 7 visits), and the lenses will be randomly assigned for wear. The primary endpoint is the changes in the tear break-up time, tear evaporation rate, and lipid layer thickness of contact lens wearer over the 8 h of lens wear. The secondary endpoint is the changes in the ocular surface and eyelids of the contact lens wearer over the 8 h of lens wear. The changes in the ocular surface will be investigated by corneal and conjunctival staining and Slit-Lamp Biomicroscopy. The objectives will be a) to measure the comfort response of people wearing lipid-imbibed contact lenses (O-L) vs control lenses (C-L) vs commercially available contact lenses (M-L). b) to measure tear break-up time (tear stability) during contact lens wear of the lenses. c) to measure and evaluate tear lipid layer thickness during contact lens wear. d) to measure corneal and conjunctival staining after contact lens wear.

Interventions

The aim of this study is to investigate changes in the ocular surface (corneal and conjunctival staining, tear break-up time, tear evaporation rate, and tear lipid layer thickness) of experienced and neophyte (new) contact lens wearers wearing lipid-laden contact lens (O-L), control contact lens (without lipids, C-L) and market contact lens (M-L). In this study, participants will randomly (crossover study) wear lipid-imbibed lenses (O-L), control lenses that contain only small particles of surf

The aim of this study is to investigate changes in the ocular surface (corneal and conjunctival staining, tear break-up time, tear evaporation rate, and tear lipid layer thickness) of experienced and neophyte (new) contact lens wearers wearing lipid-laden contact lens (O-L), control contact lens (without lipids, C-L) and market contact lens (M-L). In this study, participants will randomly (crossover study) wear lipid-imbibed lenses (O-L), control lenses that contain only small particles of surfactant with no LIPID (C-L), and normal commercially available contact lenses (M-L). The same lens will be worn in both eyes, all participants will wear all 3 lens types, and the lenses will be randomly assigned for wear. Experienced or neophyte (new) contact lens wearers who meet the inclusion criteria will be enrolled in this single-site, randomized, crossover, double-masked prospective study. At each visit (total 3 visits for three types of lenses + one visit for screening) the participant will wear (both the eyes same lens type) one of the study lenses (lipid [O-L], or Surfactant control [C-L], or Marketed lens [M-L]; for at least 8 hours. After 4-5 days (washout period), in the second visit, the second set of lenses will be worn in both eyes for at least 8 hours. In the third (last) visit (after 4-5 days) the remaining (last set of) lenses will be worn in both eyes for at least 8 hours. In every visit (for all three types of lenses), before and after contact lens wear, the participant will be asked for Contact Lens Dry Eye Questionnaires-8 (CLDEQ) [not for neophyte wearers at their first visit as they will not be wearing lenses at that time and so will use the Dry Eye Questionnaires (DEQ-5)], subjectively rate the comfort of their eyes (on a 1 to 100 scale), and the following tests will be performed: Slit-Lamp Biomicroscopy to assess the health of ocular surface and eyelids, tear evaporation rate (TER), ocular surface staining, non-invasive tear breakup time, and tear lipid layer thickness.

Sponsors

University of New South Wales
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Treatment
Masking
Blinded (masking used) (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

• Between 18-40 years old • Able to read and comprehend English and give informed consent as demonstrated by signing a record of informed consent. • Habitual contact lens wear and neophytes • Refractive correction of -0.50 to -15.50, -0.25 to -1.75 and +0.50 to +1.75 diopters for myopia, astigmatism, and hyperopia • Willing to wear the study contact lenses a minimum of 8 hours per day [in all three rounds]. • Have health and ocular health findings which would not prevent the participant from safely wearing contact lenses • Willing to not use any rewetting eye drops for the duration of the study. • Willing to refrain from swimming, showering and/or sleeping while wearing the contact lenses for the duration of the study • Willing to undergo the tests as outlined in the information statement.

Exclusion criteria

• Any active corneal infection, allergies • Acute or sub-acute inflammation of the anterior chamber, • Pregnancy (or planning pregnancy), lactating/breast feeding, suffering from the systemic diseases Sjögren’s syndrome, rheumatoid arthritis, systemic lupus erythematosus, diabetes and thyroid eye disease or taking the medications atropine, antazoline, azatadine or antihistamines such as cetirizine, brompheniramine • People who have undergone refractive surgery • People with neurological disorders such as epilepsy

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026